Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Sees Large Growth in Short Interest

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) saw a significant increase in short interest in the month of July. As of July 31st, there was short interest totaling 29,285 shares, an increase of 369.2% from the July 15th total of 6,242 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 21,150 shares, the days-to-cover ratio is currently 1.4 days.

Spectral Diagnostics Trading Down 0.2%

EDTXF stock traded down $0.00 during midday trading on Friday, hitting $1.01. The stock had a trading volume of 1,780 shares, compared to its average volume of 9,346. The firm has a market cap of $295.78 million, a P/E ratio of -10.08 and a beta of 0.13. The business has a fifty day moving average price of $0.97 and a two-hundred day moving average price of $0.99. Spectral Diagnostics has a 1-year low of $0.76 and a 1-year high of $1.27.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.